How The Ionis Pharmaceuticals (IONS) Story Is Shifting With New Targets And 2026 Catalysts [Yahoo! Finance]
Ionis Pharmaceuticals, Inc. (IONS)
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ionispharma.com
Company Research
Source: Yahoo! Finance
The updated fair value estimate for Ionis Pharmaceuticals has shifted from US$93.90 to US$96.73 per share, a modest move that still matters if you are tracking valuation closely. This change comes as recent analyst research leans constructive, with several firms lifting price targets into the US$77 to US$103 range while still flagging areas of caution around guidance and execution. Read on to see how these evolving targets, ratings, and company updates can help you follow the shifting narrative around Ionis. Stay updated as the Fair Value for Ionis Pharmaceuticals shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Ionis Pharmaceuticals. What Wall Street Has Been Saying ?? Bullish Takeaways Needham lifted its price target to US$103 from US$90 and highlighted what it called a "catalyst rich" 2026, pointing to upcoming data readouts and viewing the stock's risk or reward as favorable. Piper Sandler increase
Show less
Read more
Impact Snapshot
Event Time:
IONS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IONS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IONS alerts
High impacting Ionis Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
IONS
News
- Ionis Pharmaceuticals (IONS) was given a new $110.00 price target by Canaccord Genuity Group Inc..MarketBeat
- Ionis to hold first quarter 2026 financial results webcastBusiness Wire
- Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..MarketBeat
- Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.MarketBeat
- Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]Seeking Alpha
IONS
Earnings
- 2/25/26 - Miss
IONS
Sec Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- IONS's page on the SEC website